|Articles|August 27, 2015

Admedus Adopts the Medidata Clinical Cloud® in Vaccine Study

Admedus adopts the Medidata Clinical Cloud® to bring greater speed and efficiency to it’s genital herpes therapeutic vaccine study.

Medidata, a global provider of cloud-based solutions for clinical research in life sciences, announced that Australian-based specialist healthcare company Admedus is using its Medidata Clinical Cloud® platform in its clinical development of a therapeutic vaccine for genital herpes.

 

Read the full release here.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Related Content